Vanessa Sandford

An established leader in the Biopharmaceutical industry with over 20 years of technical and managerial experience across the product development lifecycle. A specialist in developing scalable and robust processes to supply of clinical material for plasma derived, vaccines and recombinant molecules. A strong foundation in developing strategy for process development, and process characterisation to support process validation. A passion for building highly skilled teams to achieve these important goals. Committed to embracing innovation and new sustainable approaches to delivery such as engaging with partners within and external to CSL. Versatile Executive Director focused on promoting mission and increasing effectiveness of key programs. Passionate about managing and overseeing implementation of company's daily operations. Quick and firm decision-maker possessing first-rate communication and organizational skills. Recognized for successfully collaborating with management to develop work plans, financials and strategies.

• CSL R&D, Melbourne, VIC, Australia, 13 years, Executive Director of Global Drug Product Development, 2023, current
• CSL R&D, Melbourne, VIC, Australia, 3 years, Senior Director of Drug product, Global Bioanalytics and Strategic Projects, 2020, 2023
• CSL R&D, Melbourne, VIC, Australia, 1 year, Director of Strategic Projects, 2019, 2020
• CSL R&D, Melbourne, VIC, Australia, 4 years, Director of Cell Culture and Purification Development, 2015, 2019
• CSL R&D, Melbourne, VIC, Australia, 2 years, Director of Cell Culture Development, 2013, 2015
• CSL R&D, Melbourne, VIC, Australia, 4 years, Senior Process Development Specialist, 2009, 2013
• Merck & Co, Westpoint, PA, USA, 1 year, Research Fellow, 2007, 2008
• Merck & Co, Westpoint, PA, USA, 5 years, Senior Research Biochemical Engineer, 2002, 2006
• Merck & Co, Westpoint, PA, USA, 2 years, Bioprocess Engineer, 1995, 1996
• University of NSW, Sydney, Australia, 4 years, Doctor of Philosophy (PhD): Bioprocess development for R-PAC: an intermediate for pseudoephedrine production. Scholarship sponsored by BASF Ludwigshafen, 1997, 2001
• University of NSW, Sydney, Australia, 3 years, Undergraduate degree in Chemical Engineering (Bioprocess Engineering), 1991, 1994